Recruiting PHASE4 INTERVENTIONAL 2-arm NCT06855537

Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques

Randomized Controlled Study on the Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques

Sponsor: Beijing Anzhen Hospital

Conditions Acute Coronary Syndromes (ACS) Coronary Arterial Disease (CAD) Thin-cap fIbroatheroma Vulnerable Coronary Plaques

Interventions OMT strategy PCI strategy

Updated 4 times since 2025 Last updated: Nov 25, 2025 Started: Nov 3, 2025 Primary completion: Sep 1, 2027 Completion: Sep 1, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Acute Coronary Syndromes (ACS) and Coronary Arterial Disease (CAD) and is currently actively recruiting participants. Beijing Anzhen Hospital leads this study, which shows 4 recorded versions since 2025 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

4 versions recorded

Jan 2026 — Present [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Dec 2025 — Jan 2026 [monthly]

Not Yet Recruiting PHASE4
Oct 2025 — Dec 2025 [monthly]

Not Yet Recruiting PHASE4
Apr 2025 — Oct 2025 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing Anzhen Hospital

Data source: Beijing Anzhen Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China